Inc. covered new survey research from ReturnPro examining how GLP-1 medications such as Ozempic, Wegovy, Mounjaro and Zepbound are changing apparel shopping behavior. The article draws on ReturnPro's survey of 500 U.S. adults currently or recently taking a GLP-1 medication, finding that 65 percent purchased multiple sizes intending to return items that did not fit and 61 percent delayed returns while anticipating further weight loss. ReturnPro CEO Sender Shamiss told Inc. that retailers need better sizing technology and faster reverse-logistics systems to keep pace with fast-changing body sizes. The coverage highlights ReturnPro's original research as a resource for retailers rethinking sizing, returns and exchange strategies.
